ALT Quote by Dr. Michael Osterholm, Vaccine Integrity Project Executive Director Text reads, "Immunization continues to be one of our best tools for preventing severe illness from respiratory viruses." CIDRAP and Vaccine Integrity Project logos are included.

ALT Graphic titled "VIP released an independent evidence review of respiratory virus immunizations." Includes logos of the Vaccine Integrity Project and CIDRAP. Text states, "Here's what the evidence found on the flu, COVID-19 and RSV immunizations." A rightward arrow is shown against a blue background with virus illustrations. CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The influenza review found: Among adults over 65, the flu vaccine increased protection against hospitalization by 31%.* Vaccine effectiveness was 80% against laboratory-confirmed influenza-associated deaths among infants and children aged 6 months to 17 years.** *according to an analysis of VISION Network data ** in a case-cohort analysis of national surveillance data over eight seasons (2016-2020, 2021-2025)" CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The COVID-19 review found: For adults over 65, vaccination cut the risk of COVID-related hospitalization by 53% in the 2025-26 respiratory virus season.  Maternal vaccination lowered the risk of emergency department and urgent care visits for pregnant women by 58% and to infants aged 0-2 months too with a vaccine effectiveness range of 50-54%. Vaccinated young children (9 months-4 years) saw a 76% reduction in COVID-related pediatric emergency department visits." CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The RSV review found: For adults over 60, studies showed significant protection against hospitalization, with vaccine effectiveness ranging from 69%-83% within the same season as vaccination. Vaccination during pregnancy reduced the risk of RSV among vaccinees by 82% and also reduced the risk of RSV-associated hospitalization among infants born subsequently. The infant monoclonal antibody immunization nirsevimab reduced the risk of RSV-related hospitalization by 64%-93% within 6-12 months." CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT Graphic with the title "What to know: The Vaccine Integrity Project’s independent evidence review of respiratory virus immunizations: Influenza, COVID-19, and respiratory syncytial virus (RSV)." Features the logos of the Vaccine Integrity Project and CIDRAP, with a blue arrow pointing to the right. The background is a teal gradient with a dotted pattern.

ALT The image is a graphic from The Vaccine Integrity Project. Text reads, "The Vaccine Integrity Project reviewed hundreds of peer-reviewed studies published since August 2025, building on its 2025-26 evidence review of vaccine effectiveness, safety and disease epidemiology data. The evidence found that these immunizations continue to provide meaningful protection against severe illness, hospitalization and death." The background is teal with dots, and the website vaxintegrity.cidrap.umn.edu is included at the bottom.

ALT The image contains text on a teal background promoting the Vaccine Integrity Project and CIDRAP. Graphic with arrow pointing to text that reads, "Led by the Vaccine Integrity Project, the review also examined new safety data published since summer 2025 and identified no new safety concerns in comparative studies when examining currently recommended immunizations." The Vaccine Integrity Project's website address vaxintegrity.cidrap.umn.edu is in the bottom right corner.

ALT The image contains text on a teal background promoting the Vaccine Integrity Project and CIDRAP. It features an arrow pointing to text, "Based on the most recent peer-reviewed data, the review gives Americans the information they need to make vaccination decisions that will help protect themselves and their families from the three leading causes of serious respiratory virus-related illness." Logos for the Vaccine Integrity Project and CIDRAP are at the bottom, next to the website address vaxintegrity.cidrap.umn.edu.